Sökning: onr:"swepub:oai:DiVA.org:su-224253" >
Cultured lymphocyte...
Cultured lymphocytes' mitochondrial genome integrity is not altered by cladribine
-
Jaervinen, Elina (författare)
-
Suomi, Fumi (författare)
-
Stewart, James B. (författare)
-
visa fler...
-
- Guala, Dimitri, 1979- (författare)
- Stockholms universitet,Institutionen för biokemi och biofysik,Science for Life Laboratory (SciLifeLab)
-
Valori, Miko (författare)
-
Jansson, Lilja (författare)
-
Nieminen, Janne (författare)
-
McWilliams, Thomas G. (författare)
-
Tienari, Pentti J. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: Clinical and Experimental Immunology. - 0009-9104 .- 1365-2249. ; 214:3, s. 304-313
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Cladribine tablets are a treatment for multiple sclerosis with effects on lymphocytes, yet its mode of action has not been fully established. Here, we analyzed the effects of cladribine on mitochondrial DNA integrity in lymphocytes. We treated cultured human T-cell lines (CCRF-CEM and Jurkat) with varying concentrations of cladribine to mimic the slow cell depletion observed in treated patients. The CCRF-CEM was more susceptible to cladribine than Jurkat cells. In both cells, mitochondrial protein synthesis, mitochondrial DNA copy number, and mitochondrial cytochrome-c oxidase-I mRNA mutagenesis was not affected by cladribine, while caspase-3 cleavage was detected in Jurkat cells at 100 nM concentration. Cladribine treatment at concentrations up to 10 nM in CCRF-CEM and 100 nM in Jurkat cells did not induce significant increase in mitochondrial DNA mutations. Peripheral blood mononuclear cells from eight multiple sclerosis patients and four controls were cultured with or without an effective dose of cladribine (5 nM). However, we did not find any differences in mitochondrial DNA somatic mutations in lymphocyte subpopulations (CD4+, CD8+, and CD19+) between treated versus nontreated cells. The overall mutation rate was similar in patients and controls. When different lymphocyte subpopulations were compared, greater mitochondrial DNA mutation levels were detected in CD8+ (P = 0.014) and CD4+ (P = 0.038) as compared to CD19+ cells, these differences were independent of cladribine treatment. We conclude that T cells have more detectable mitochondrial DNA mutations than B cells, and cladribine has no detectable mutagenic effect on lymphocyte mitochondrial genome nor does it impair mitochondrial function in human T-cell lines. Cultured leukemic human T-cell lines and cultured ex vivo human peripheral mononuclear cells from patients with multiple sclerosis and controls were treated with cladribine in vitro . In the T-cell lines mitochondrial protein synthesis, DNA copy number and mutagenesis were not affected by cladribine. In the ex vivo lymphocyte subpopulations (CD4+, CD8+, and CD19+), there were no significant differences in mitochondrial DNA mutations between treated versus nontreated cells. Graphical Abstract
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- cladribine
- multiple sclerosis
- mitochondrial DNA
- lymphocytes
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Jaervinen, Elina
-
Suomi, Fumi
-
Stewart, James B ...
-
Guala, Dimitri, ...
-
Valori, Miko
-
Jansson, Lilja
-
visa fler...
-
Nieminen, Janne
-
McWilliams, Thom ...
-
Tienari, Pentti ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Clinical and Exp ...
- Av lärosätet
-
Stockholms universitet